Literature DB >> 11931726

Peripheral Neuropathy Due to Cobalamin Deficiency.

David S. Saperstein1, Richard J. Barohn.   

Abstract

Vitamin B12, or cobalamin (Cbl), deficiency can produce a number of neurologic complications, including myelopathy, peripheral neuropathy, optic neuropathy, and dementia. The myelopathy, combined systems disease, is probably the most well known manifestation, and is usually readily recognized. The frequency with which peripheral neuropathy is the sole presenting feature of Cbl deficiency is a point of controversy. The prevalence and the clinical and electrophysiologic features of Cbl deficiency peripheral neuropathy have not been well characterized. In addition, there is evidence that the commonly used assays of serum Cbl are not adequately sensitive. Testing the serum metabolites methylmalonic acid and homocysteine can increase the identification of Cbl deficient patients. Treatment with parenteral Cbl injections may not produce improvement of neurologic deficits, but might prevent worsening. In some patients with Cbl deficiency, oral Cbl may be an effective therapy.

Entities:  

Year:  2002        PMID: 11931726     DOI: 10.1007/s11940-002-0036-y

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  27 in total

1.  Neurologic aspects of cobalamin deficiency.

Authors:  E B Healton; D G Savage; J C Brust; T J Garrett; J Lindenbaum
Journal:  Medicine (Baltimore)       Date:  1991-07       Impact factor: 1.889

2.  The neurophysiological profile of vitamin B12 deficiency.

Authors:  E J Fine; E Soria; M W Paroski; D Petryk; L Thomasula
Journal:  Muscle Nerve       Date:  1990-02       Impact factor: 3.217

Review 3.  Current concepts in cobalamin deficiency.

Authors:  R Carmel
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

4.  Further studies on the use of serum gastrin levels in assessing the significance of low serum B12 levels.

Authors:  A Miller; D W Slingerland; J Cardarelli; B A Burrows
Journal:  Am J Hematol       Date:  1989-07       Impact factor: 10.047

5.  The significance of subnormal serum vitamin B12 concentration in older people: a case control study.

Authors:  J Metz; A H Bell; L Flicker; T Bottiglieri; J Ibrahim; E Seal; D Schultz; H Savoia; K M McGrath
Journal:  J Am Geriatr Soc       Date:  1996-11       Impact factor: 5.562

6.  Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics.

Authors:  G I Wolfe; N S Baker; A A Amato; C E Jackson; S P Nations; D S Saperstein; C H Cha; J S Katz; W W Bryan; R J Barohn
Journal:  Arch Neurol       Date:  1999-05

7.  Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Italian General Practitioner Study Group (IGPSG).

Authors: 
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

8.  'Anesthesia paresthetica': nitrous oxide-induced cobalamin deficiency.

Authors:  L J Kinsella; R Green
Journal:  Neurology       Date:  1995-08       Impact factor: 9.910

9.  Effective treatment of cobalamin deficiency with oral cobalamin.

Authors:  A M Kuzminski; E J Del Giacco; R H Allen; S P Stabler; J Lindenbaum
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

Review 10.  Malabsorption of food cobalamin.

Authors:  R Carmel
Journal:  Baillieres Clin Haematol       Date:  1995-09
View more
  13 in total

Review 1.  Alcoholic neuropathy: possible mechanisms and future treatment possibilities.

Authors:  Kanwaljit Chopra; Vinod Tiwari
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

2.  Vitamin B12 and Homocysteine Associations with Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging.

Authors:  M L Vidoni; K Pettee Gabriel; S T Luo; E M Simonsick; R S Day
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs.

Authors:  Kira Leishear; Luigi Ferrucci; Fulvio Lauretani; Robert M Boudreau; Stephanie A Studenski; Caterina Rosano; Rosanna Abbate; Anna M Gori; Anna M Corsi; Angelo Di Iorio; Jack M Guralnik; Stefania Bandinelli; Anne B Newman; Elsa S Strotmeyer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-12       Impact factor: 6.053

Review 4.  The role of metformin on vitamin B12 deficiency: a meta-analysis review.

Authors:  Mitra Niafar; Faizi Hai; Jahan Porhomayon; Nader Djalal Nader
Journal:  Intern Emerg Med       Date:  2014-12-13       Impact factor: 3.397

5.  Relationship between vitamin B12 and sensory and motor peripheral nerve function in older adults.

Authors:  Kira Leishear; Robert M Boudreau; Stephanie A Studenski; Luigi Ferrucci; Caterina Rosano; Nathalie de Rekeneire; Denise K Houston; Stephen B Kritchevsky; Ann V Schwartz; Aaron I Vinik; Eva Hogervorst; Kristine Yaffe; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  J Am Geriatr Soc       Date:  2012-06       Impact factor: 5.562

Review 6.  Nutritional neuropathies.

Authors:  Nancy Hammond; Yunxia Wang; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

7.  Pattern-recognition approach to neuropathy and neuronopathy.

Authors:  Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

8.  Perturbation of neuronal cobalamin transport by lysosomal enzyme inhibition.

Authors:  Hua Zhao; Kalani Ruberu; Hongyun Li; Brett Garner
Journal:  Biosci Rep       Date:  2014-02-01       Impact factor: 3.840

9.  Peak bone mass in patients with phenylketonuria.

Authors:  D Modan-Moses; I Vered; G Schwartz; Y Anikster; S Abraham; R Segev; Ori Efrati
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

10.  Pseudo-Foster Kennedy Syndrome as a Rare Presentation of Vitamin B12 Deficiency.

Authors:  Peyman Petramfar; Farideh Hosseinzadeh; S Saeed Mohammadi
Journal:  Iran Red Crescent Med J       Date:  2016-05-14       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.